# Nephros, Inc

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Nephros, Inc).

## Overview

Nephros, Inc. develops and sells water filtration and ultrafiltration products used in healthcare and commercial settings. Its systems are designed to improve water quality and help reduce infection and contamination risks in hospitals, dialysis centers, and foodservice or hospitality facilities.

## Products & services

• Ultrafiltration products for hospitals and healthcare facilities
• Water filtration for dialysis centers and home dialysis machines
• Commercial water filters for foodservice, hospitality, and convenience stores
• Filters for ice machines, beverage dispensers, and drinking water
• Service, installation, and maintenance support through contractors

- **Healthcare water filtration** (55%) — Ultrafilters and related products used in hospitals and medical facilities to reduce waterborne pathogens.
- **Dialysis water treatment** (15%) — Filtration products used in dialysis centers and dialysis equipment to remove biological contaminants.
- **Commercial water filtration** (25%) — Filters sold into foodservice, hospitality, convenience store, and industrial applications.
- **Services and support** (5%) — Installation, servicing, maintenance, and technical support for deployed systems.

- Ultrafiltration products for hospitals and healthcare facilities
- Water filtration for dialysis centers and home dialysis machines
- Commercial water filters for foodservice, hospitality, and convenience stores
- Filters for ice machines, beverage dispensers, and drinking water
- Service, installation, and maintenance support through contractors

## Customers

Nephros sells to hospitals, dialysis providers, and other healthcare facilities that need water filtration for infection control and clinical use. It also serves commercial customers such as hotels, restaurants, casinos, convenience stores, and food and beverage operators that want better water quality for consumption and equipment protection. The company relies on a mix of direct sales and distributors, especially in commercial markets.

- **Hospitals and other healthcare facilities** (primary) — Buy ultrafilters for infection control, patient safety, and waterborne pathogen reduction.
- **Dialysis centers and dialysis equipment users** (primary) — Buy filtration products for hemodialysis water and bicarbonate concentrate treatment.
- **Commercial foodservice and hospitality** (primary) — Buy water filters for ice machines, beverage systems, and drinking water quality.
- **Convenience stores and restaurants** (secondary) — Buy filtration products to improve water taste, odor, and equipment performance.
- **Distributors and service partners** (secondary) — Buy and resell products or provide installation and service to end customers.

- Hospitals and healthcare facilities buying infection-control filtration
- Dialysis centers needing purified water and bicarbonate concentrate filtration
- Home and portable dialysis users through equipment channels
- Hotels, restaurants, casinos, and convenience stores for water quality
- Food and beverage operators seeking taste, odor, and scale reduction

## Geography

Nephros is a U.S.-based company with corporate headquarters, research, manufacturing, and distribution facilities in New Jersey. The filings do not provide a country revenue split, but the business appears centered on the United States with commercial and healthcare customers served through direct sales and distribution partners. Geography matters because the company’s growth depends on building local service and distribution coverage in each market it enters.

- Headquartered in the United States, with facilities in New Jersey
- Primary operations include research, manufacturing, and distribution in New Jersey
- Commercial growth depends on distribution partners in target markets
- Service coverage must be built locally for installation and maintenance
- No country-level revenue split was disclosed in the excerpts

## Strategy

Nephros is focused on growing sales of its water filtration products while controlling operating costs and preserving liquidity. Management is also working to expand distribution, strengthen service coverage, and support demand in both healthcare and commercial markets. Product acceptance, regulatory compliance, and the ability to maintain positive operating cash flow are central to the strategy.

- **Expand commercial distribution** (short-term) — Commercial growth now depends on new partners after the Donastar relationship ended.
- **Maintain and grow healthcare adoption** (medium-term) — Hospitals and dialysis centers are core end markets for the ultrafiltration platform.
- **Improve operating cash flow** (short-term) — The company wants to fund operations internally and reduce financing dependence.

- Grow sales of water filtration products in healthcare and commercial markets
- Expand distribution partners after the Donastar termination
- Build service and maintenance coverage where products are sold
- Control operating costs to support positive operating cash flow
- Invest in product development, marketing, and sales execution

## Risks

Nephros depends on third-party contractors and distributors to install, service, and sell its products, so execution failures can directly hurt revenue and reputation. The company also faces regulatory and product-compliance risk because its medically approved products are subject to FDA and other rules, while commercial demand can fluctuate with customer budgets, competition, and emergency-response buying patterns. As a smaller company, it also faces customer concentration, supply-chain dependence, and liquidity sensitivity if demand weakens.

- **Reliance on third-party contractors for installation and service** [high] — Poor service quality or delays can damage product performance, compliance, and customer trust.
- **Dependence on new distribution partners in commercial markets** [high] — After the Donastar termination, commercial sales growth depends on partner execution.
- **Regulatory compliance and FDA oversight** [high] — Medical-use products are subject to testing, labeling, distribution, and approval rules.
- **Supply-chain dependence on third-party product suppliers** [medium] — The company is vulnerable to supply disruptions and price fluctuations.
- **Demand volatility in emergency-response sales** [medium] — Management noted elevated emergency-response sales may not persist.

- Third-party installers and service providers may fail to perform adequately
- Commercial growth depends on new distributors after a key relationship ended
- FDA and other regulatory requirements can trigger fines, recalls, or delays
- Supply dependence on third-party manufacturers creates pricing and availability risk
- Demand can be volatile, especially in emergency-response sales
- Small-company liquidity is sensitive to sales shortfalls and cost overruns

## Accounting

Nephros recognizes most product revenue at a point in time when goods ship, so shipment timing and distributor ordering patterns can move quarterly results. The company also uses estimates for variable consideration, inventory reserves, and standalone selling prices for bundled products and services, which can affect gross margin and revenue timing. Goodwill, finite-lived intangibles, and stock-based compensation are additional judgment areas that can influence reported earnings and asset values.

- **Point-in-time revenue recognition** — Quarterly revenue and margin volatility
- **Variable consideration estimates** — Net revenue and gross margin
- **Inventory reserves and write-offs** — Gross profit and operating income
- **Goodwill and intangible asset impairment** — Non-cash charges to earnings
- **Stock-based compensation** — Operating expense and net income

- Product revenue is recognized when shipped, affecting quarter-to-quarter timing
- Variable consideration includes discounts, returns, and allowances
- Service revenue is recognized when the service is completed
- Inventory reserves and write-offs can move gross margin
- Goodwill and intangibles require impairment and useful-life judgments

---

*Last updated: 2026-04-28T20:28:26.239876+00:00*